Medical and Pharmaceutical University Hospital
Ho Chi Minh City, Five, 70000, Vietnam
Location status: Recruiting
NCT Number: NCT06163768
Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Ho Chi Minh City, Five, 70000, Vietnam
Location status: Recruiting
Help patients know about insulin resistance. If this condition persists for a long time, it will reduce the ability to produce insulin, thereby leading to increased blood sugar levels, causing type 2 diabetes. Helping doctors have a more general view, in order to come up with a strategy more effective monitoring and treatment, preventing diabetes and cardiovascular events.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Steps to conduct testing and treatment according to the approved regimen at Ho Chi Minh City University of Medicine and Pharmacy Hospital. The researcher did not intervene in the treatment process.
Time frame: January 2026
Use SPSS software to analyze data
Contact information is provided by the study sponsor or research team.
University of Medicine and Pharmacy at Ho Chi Minh City
Other
Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients by the Homeostasis Model Assessment Index (HOMA2-IR)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724522
Body Weight, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05933707
Body Weight, Body Weight Changes
St Louis, Missouri, United States
View Trial DetailsNCT01143480
Arterial Occlusive Diseases, Arteriosclerosis
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT07690163
Body Weight, Diabetes Mellitus
Kyiv, Ukraine
View Trial Details